Skip to main content
. 2013 Mar 20;99(1):24–34. doi: 10.1093/cvr/cvt064

Figure 5.

Figure 5.

17β-Oestradiol and Dfen have synergistic effects on PAH-PASMC proliferation. 17β-Oestradiol mediates an increase in (A) CYP1B1 (n = 3) and (B) Tph1 (n = 3) expression in PAH-PASMCs. (C) Dfen and 17β-oestradiol have synergistic effects on proliferation of PAH-PASMCs (n = 3). Data are expressed as mean ± SEM. Data were analysed by one-way ANOVA followed by Dunnett's post-test. *P < 0.05 vs. 0.3 µM Dfen P < 0.01 vs. 0.1 nM 17β-estradiol, **P < 0.01 vs. control.